Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Syneron Medical Ltd. Stories

2014-04-16 12:29:50

IRVINE, Calif., April 16, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today details for its previously announced conference call and webcast to discuss the United States Food and Drug Administration (FDA) 510(k) clearance of the UltraShape(TM) System for selective non-invasive fat cell destruction for the purpose of body contouring. http://photos.prnewswire.com/prnvar/20120528/535447 The...

2014-04-14 12:34:57

IRVINE, California, April 14, 2014 /PRNewswire/ -- Positions Syneron with Disruptive Product Offering in Fast Growing Body Contouring and Fat Treatment Market Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to market the UltraShape...

2014-04-04 08:25:51

Presentation on VelaShape III Receives Prestigious Dr. Richard E. Fitzpatrick Clinical Research and Innovations Award YOKNEAM ILLIT, Israel, April 4, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that the Syneron Candela's leading products will be featured in presentations at LASER 2014, the 34th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS), April 2-6 in Phoenix, AZ. This...

2014-04-03 04:20:50

LONDON, April 3, 2014 /PRNewswire/ -- Expanded Sublative Indication to be Unveiled at AMWC in Monaco Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that its proprietary Sublative(TM) technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars. The new treatment protocols are now available on all of the Syneron Sublative compatible systems, which...

2014-03-24 08:29:44

YOKNEAM ILLIT, Israel, March 24, 2014 /PRNewswire/ -- Syneron Medical Ltd. (Nasdaq: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F, containing audited consolidated financial statements for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on March 19, 2014, is available on its website (www.syneron.com). Shareholders may receive a hard copy of the annual report free of charge upon request. This...

2014-03-21 08:25:22

New applicator for treatment of cellulite; Single treatment tip for body contouring; New applicators for high speed hair removal and skin rejuvenation. IRVINE, Calif., March 21, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, will showcase technology that shapes the future of aesthetics at the 72(nd) Annual Meeting of the American Academy of Dermatology (AAD) in Denver March 21-25, 2014....

2014-03-03 16:26:05

YOKNEAM, Israel, March 3, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to present at the Barclays Global Healthcare Conference in Miami, FL. This conference will allow institutional investors to meet with the Company and includes a formal presentation. http://photos.prnewswire.com/prnvar/20120528/535447 Conference: Barclays Global...

2014-02-20 08:29:31

CoolTouch family of products provides entry into significant new aesthetic market segments and expands Syneron's recurring revenue business model YOKNEAM, Israel, Feb. 20, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that it has entered into an agreement to acquire New Star Lasers, Inc., which conducts business as CoolTouch, Inc. ("CoolTouch"), for approximately $11 million in cash and earn out based on certain...

2014-02-04 16:29:12

YOKNEAM, Israel, Feb. 4, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is scheduled to participate in the Leerink Swann 2014 Global Healthcare Conference in New York City. Mr. Goldman will participate in a fireside chat presentation at the conference and will conduct meetings with institutional investors. (Logo: http://photos.prnewswire.com/prnh/20120528/535447)...

2014-01-27 08:28:45

YOKNEAM, Israel, Jan. 27, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, today announced that it will release fourth quarter and full year 2013 financial results before the market opens on Thursday, February 20, 2014. The financial results press release will be available on Syneron's website at investors.syneron.com. (Logo: http://photos.prnewswire.com/prnh/20120528/535447 ) Syneron management will host a conference call and...